Loading

District of Columbia

  • by Paul Armentano, NORML Deputy Director March 4, 2014

    Members of the Washington DC City Council gave final approval today to legislation reducing the District’s marijuana possession penalties to a fine-only violation.

    District lawmakers voted 10 to 1 in favor of “The Simple Possession of Small Quantities of Marijuana Decriminalization Amendment Act of 2013,” which amends District law involving the possession or transfer of up to one ounce of marijuana from a criminal misdemeanor (punishable by up to 6 months incarceration and a maximum fine of $1,000) to a civil violation (punishable by a $25 fine, no arrest, no jail time, and no criminal record). Democrat Mayor Vincent C. Gray said that he intends to sign the measure into law.

    Offenses involving the public consumption of cannabis remain classified as a criminal misdemeanor under DC law, punishable by up to six-months in jail and a $500 fine. The possession of cannabis-related paraphernalia will be re-classified as a violation, not a criminal offense.

    Once signed into law, the measure faces a 60-day review period by members of Congress.

    The District measure is similar to existing ‘decriminalization’ laws in California, Connecticut, Maine, Massachusetts, Nebraska, New York, Oregon, Rhode Island, and Vermont where private, non-medical possession of marijuana is treated as a civil, non-criminal offense.

    Five additional states – Minnesota, Mississippi, Nevada, North Carolina, and Ohio – treat marijuana possession offenses as a fine-only misdemeanor offense.

    Three states – Alaska, Colorado, and Washington – impose no criminal or civil penalty for the private possession of small amounts of marijuana.

    A 2012 analysis published by the American Civil Liberties Union of Maryland reported that the District possesses the highest percentage of marijuana possession arrests per capita in the nation.

  • by Allen St. Pierre, NORML Executive Director April 11, 2012

    From the International Association for Cannabinoid Medicines
    IACM-Bulletin of 8 April 2012

    World: Increasing numbers of patients use cannabis for medicinal purposes

    An increasing number of patients in the world are using cannabis for therapeutic reasons, with available data from countries, which have installed programs for their citizens. Good data are available for Israel, Canada, the Netherlands and many states of the US with medicinal cannabis laws and registries. In several more countries only a few patients are allowed to use cannabis for medicinal purposes, including Germany, Norway, Finland and Italy. In many other countries such as Spain and some states of the US without a registry such as California the number of medicinal users is estimated to be high, but no detailed data are available.

    The numbers in California with hundreds of cannabis dispensaries and clinics that issue medical cannabis recommendations are unclear, since the state does not require residents to register as patients (see below**)
    Most of the 16 states that allow the medicinal use of cannabis require a registration. Recently the press agency Associated Press published data on registered patients in different states of the USA based on state agencies responsible for maintaining patient registries:

    State: Number of registered patients (per 1,000 of the whole population) —
    Colorado: 82,089 (16.3)
    Oregon: 57,386 (15.0)
    Montana: 14,364 (14.5)
    Michigan: 131,483 (13.3)
    Hawaii: 11,695 (8.6)
    Rhode Island: 4,466 (4.2)
    Arizona: 22,037 (3.5)
    New Mexico: 4,310 (2.1)
    Maine: 2,708 (2.0)
    Nevada: 3,388 (1.3)
    Vermont: 505 (0.8)
    Alaska: 538 (0.8)
    Patient registration is mandatory in Delaware, New Jersey and the District of Columbia (Washington D.C.), but their registries are not yet up and running. Washington State has neither voluntary nor mandatory registration.

    Data from Israel show that in August 2011 6,000 patients got medicinal cannabis (0.8 patients in 1,000). It is estimated that the number increases to 40,000 in 2016 (5.2 patients in 1,000 citizens).

    In Canada 12,116 patients were allowed to use cannabis on 30 September 2011 (0.35 patients in 1,000 citizens).

    Numbers of patients using cannabis from the pharmacies in the Netherlands were estimated to be 1,300 in 2010 (0.08 patients in 1,000 citizens). However, many patients in the Netherlands use cannabis from the coffee shops or grow their own.

    In Germany about 60 patients are currently allowed to use cannabis for medicinal purposes.

    (Sources: Associated Press of 24 March 2012, website of the Israeli Prime Minister of 7 August 2011, UPI of 31 October 2011, Pharmaceutisch Weekblad No. 20, 2011)

    **[Editor’s note: CA NORML published a white paper last May estimating that California has 750,000 – 1,125,000 citizens who possess a physician’s recommendation to use cannabis medicinally.]

  • by Paul Armentano, NORML Deputy Director November 18, 2010

    It was a little over a year ago when the United States Department of Justice announced that it would back away from pursuing cases against medical marijuana patients and providers who are acting in accordance with state and local laws.

    “As a general matter, pursuit of [federal law enforcement] priorities should not focus federal resources … on individuals whose actions are in clear and unambiguous compliance with existing state laws providing for the medical use of marijuana,” The DOJ announced on October 19, 2009. “For example, prosecution of individuals with cancer or other serious illnesses who use marijuana as part of a recommended treatment regimen consistent with applicable state law, or those caregivers in clear and unambiguous compliance with existing state law who provide such individuals with marijuana, is unlikely to be an efficient use of limited federal resources.”

    Apparently Michelle Leonhart, President Obama’s nominee to direct the United States Drug Enforcement Administration, didn’t get the memo.

    Speaking yesterday before the Senate Judiciary Committee, on day one of her Senate confirmation process, Leonhart pledged to ignore the administration’s formal medical marijuana guidelines.

    Michele Leonhart one step closer to officially heading up the DEA
    via The Daily Caller

    [excerpt] Acting director Michele Leonhart is that much closer to officially heading up the Drug Enforcement Agency after successfully navigating a hearing with the Senate Judiciary Committee on Wednesday.

    If confirmed to the position she’s already held for three years, Leonhart said she would expand the DEA’s anti-cartel operations in Mexico and continue to enforce federal drug laws in states where medical marijuana is legal.

    … Perhaps due to the failure of Prop 19 in California (and despite the passage of medical marijuana in Arizona), Kohl, along with Democratic Sens. Sheldon Whitehouse of Rhode Island and Al Franken of Minnesota, made no mention of medical marijuana. Republican Sen. Jeff Sessions of Alabama, however, made it his prime focus.

    “I’m a big fan of the DEA,” said Sessions, before asking Leonhart point blank if she would fight medical marijuana legalization.

    “I have seen what marijuana use has done to young people, I have seen the abuse, I have seen what it’s done to families. It’s bad,” Leonhart said. “If confirmed as administrator, we would continue to enforce the federal drug laws.”

    “These legalization efforts sound good to people,” Sessions quipped. “They say, ‘We could just end the problem of drugs if we could just make it legal.’ But any country that’s tried that, Alaska and other places have tried it, have failed. It does not work,” Sessions said.

    “We need people who are willing to say that. Are you willing to say that?” Sessions asked Leonhart.

    “Yes, I’ve said that, senator. You’re absolutely correct [about] the social costs from drug abuse, especially from marijuana,” Leonhart said. “Legalizers say it will help the Mexican cartel situation; it won’t. It will allow states to balance budgets; it won’t. No one is looking [at] the social costs of legalizing drugs.”

    It is shocking to learn that not a single Senator who attended the hearing, in particular Democrat Sen. Sheldon Whitehouse from Rhode Island, had the courage to demand that Ms. Leonhart respect the laws of the 15 states that have legalized the use of marijuana as a medicine. In the case of Sen. Whitehouse, his own state is now in the process of licensing state-certified marijuana providers and distributors; yet he appears to have no problem with the idea of appointing a federal official who declares her intention to put his own constituents in federal prison.

    It gets even more disturbing. In the days leading up to Wednesday’s initial confirmation hearing, a coalition of advocacy groups — including NORML, Americans for Safe Access, and others called on members of the Senate Judiciary to ask Ms. Leonhart tough questions regarding her public record, one that is incompatible with state laws, public opinion, and with the policies of this administration. Yet not a single Senator did so.

    There is a growing divide between state and federal law concerning the use of marijuana for medical purposes, and it would only take members of the Senate — or Ms. Leonhart for that matter — a cursory scan of today’s google headlines to see it:

    Prop 203 Passes: Medical Marijuana to Be Legal in Arizona
    via CBS News

    New Mexico approves six new medical marijuana producers
    via The New Mexico Independent

    Maine couple cleared to open marijuana clinic
    via The Associated Press

    DC revises medical marijuana regulations
    via Comcast

    As we’ve written before, as Interim DEA director, Ms. Leonhart has overseen dozens of federal raids on medical marijuana providers, producers, and laboratory facilities that engage in the testing of cannabis potency and quality. Yesterday Ms. Leonhart pledged to continue these actions — actions that violate this administration’s own written policies, and more importantly, actions that target the civilians of fifteen states and the District of Columbia. These people are the constituents of 30 percent of the U.S. Senate; yet not even one of these elected officials appears willing to speak up for them. That is disgraceful.

    Want to write or call your Senator about Ms. Leonhart’s nomination process? You can still do so here and here.

  • by Paul Armentano, NORML Deputy Director February 11, 2010

    Lawmakers around the country are debating a record number of marijuana law reform bills in 2010. NORML’s Weekly Legislative Round Up is your one-stop guide to pending marijuana law reform legislation around the country, along with tips for influencing the policies of your state.

    ** A note to first time readers: NORML can not introduce legislation in your state. Nor can any other non-profit advocacy organization. Only your state representatives, or in some cases an individual constituent (by way of their representative; this is known as introducing legislation ‘by request’) can do so. NORML can — and does — work closely with like-minded politicians and citizens to reform marijuana laws, and lobbies on behalf of these efforts. But ultimately the most effective way — and the only way — to successfully achieve statewide marijuana law reform is for local stakeholders and citizens to become involved in the political process and make the changes they want to see. We can’t do it without you.

    Washington: Senate lawmakers voted 37 to 11 in favor of Senate Bill 5798, which seeks to expand the state’s nearly twelve-year-old medical marijuana law. As approved, SB 5798 allows certain health care professionals – including naturopaths, physician’s assistants, osteopathic physicians, and advanced registered nurse practitioners – to legally recommend marijuana therapy to their patients. Under present law, only licensed physicians may legally recommend medicinal cannabis.

    Senate Bill 5798 now awaits action from House lawmakers. The measure is scheduled to be heard by members of the House Committee on Health Care & Wellness on Thursday, February 18. You can contact members of the House in favor of the bill here.

    New Hampshire: Members of the House Criminal Justice and Public Safety Committee voted 16 to 2 today in favor of House Bill 1653. As amended by the Committee, this proposal reduces the penalties for minor marijuana possession offenses (up to 1/4 of one ounce) from a criminal misdemeanor punishable by up to one year in jail and a $2,000 fine to a nominal monetary penalty of no more than $200.00 (and no criminal record). You can contact your member of the House and urge them to support HB 1653 by visiting NORML’s ‘Take Action Center’ here.

    Washington, DC: Members of the DC City Council’s Committee on Health postponed their first hearing (scheduled for today) on implementing the District’s new medical marijuana law because of inclement weather. The hearing will likely be rescheduled for next week. (Check here for new date and time.) You can read NORML’s written testimony to the Committee here.

    Tennessee: On Tuesday, February 16 from 9am-2pm, Tennessee NORML is hosting a legislative “Day on the Hill” at the capitol in Nashville to lobby on behalf of the the Tennessee Safe Access to Medical Cannabis Act. To participate in this event and show your support for medical marijuana law reform in Tennessee, please visit here.

    For information on additional state and federal marijuana law reform legislation, please visit NORML’s ‘Take Action Center’ here.